EFFICACY OF TETRAHYDROCANNABINOL IN PATIENTS REFRACTORY TO STANDARD ANTIEMETIC THERAPY

被引：0
|
作者：
MCCABE, M [1 ]
SMITH, FP [1 ]
MACDONALD, JS [1 ]
WOOLLEY, PV [1 ]
GOLDBERG, D [1 ]
SCHEIN, PS [1 ]
机构：
[1] GEORGETOWN UNIV,MED CTR,VINCENT T LOMBARDI CANC RES CTR,DEPT MED,DIV MED ONCOL,WASHINGTON,DC 20007
来源：
INVESTIGATIONAL NEW DRUGS | 1988年 / 6卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：243 / 246
页数：4
相关论文
共 50 条
  • [31] Prospective randomized trial of standard antiemetic therapy with yoga versus standard antiemetic therapy alone for highly emetogenic chemotherapy-induced nausea and vomiting in South Asian population
    Kothari, Trupti O.
    Jakhar, S. L.
    Bothra, Dhirendra
    Sharma, Neeti
    Kumar, H. S.
    Baradia, M. R.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (05) : 1120 - 1123
  • [32] Antiemetic efficacy of metoclopramide in patients undergoing cardiac surgery
    Montes, FR
    Encizo, C
    Noble, R
    ANESTHESIOLOGY, 1999, 91 (3A) : U478 - U478
  • [33] A new standard antiemetic regimen for patients receiving cisplatin chemotherapy
    Nature Clinical Practice Oncology, 2006, 3 (9): : 467 - 468
  • [34] EFFICACY OF ETOPOSIDE AND MITOXANTRONE IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA REFRACTORY TO STANDARD INDUCTION THERAPY AND INTERMEDIATE-DOSE CYTARABINE WITH AMSIDINE
    DAENEN, S
    LOWENBERG, B
    SONNEVELD, P
    VANPUTTEN, WLJ
    VERHOEF, G
    VANVELDHOVEN, M
    HUIJGENS, PC
    LEUKEMIA, 1994, 8 (01) : 6 - 10
  • [35] Antiemetic therapy
    Gralla, RJ
    SEMINARS IN ONCOLOGY, 1998, 25 (05) : 577 - 583
  • [36] Antiemetic therapy
    Licitra, L
    Spinazzé, S
    Roila, F
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 43 (01) : 93 - 101
  • [37] ANTIEMETIC EFFICACY OF DEXAMETHASONE
    AAPRO, MS
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) : 263 - 263
  • [38] Antiemetic therapy
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (02) : 57 - 57
  • [39] Nasobiliary Drainage for Benign Recurrent Intrahepatic Cholestasis in Patients Refractory to Standard Therapy
    Yakar, Tolga
    Demir, Mehmet
    Gokturk, Huseyin S.
    Kanat, Ayse G. Unler
    Parlakgumus, Alper
    Ozer, Birol
    Serin, Ender
    CLINICAL AND INVESTIGATIVE MEDICINE, 2016, 39 (06): : S164 - S172
  • [40] Imatinib in Patients with Severe Pulmonary Artery Hypertension (PAH) Refractory to Standard Therapy
    Ghofrani, H. A.
    Morrel, N. W.
    Hoeper, M. M.
    Olschewski, H.
    Peacock, D.
    Barst, R. J.
    Shapiro, S.
    Golpon, H.
    Toshner, M.
    Grimminger, F.
    Pascoe, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345